Abstract:OBJECTIVE:To explore the effects of transcription factor SOX9 on chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells (hUC-MSCs).METHODS:hUC-MSCs were harvested from human umbilical cord and their phenotypic characteristics identified by flow cytometry. To confirm their multipotency, hUC-MSCs were induced to differentiate toward adiposity and osteogenesis. After transfection with the packaging lentivirus vectors containing SOX9 in vitro, the expression of green fluorescent protein (GFP) and the efficiency of transfection were detected by fluorescence microscopy. Their cellular proliferation capacity was detected by thiazolyl blue tetrazolium bromide (MTT) assay.hUC-MSCs modified with SOX9 were seeded into monolayer and cultured for 21 days in a defined, serum-free medium supplemented with transforming growth factor (TGF)-β1. The untransduced cells or those transduced with GFP served as the controls. Morphologic changes of hUC-MSCs were observed daily and their chondrogenic differentiation was evaluated by reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunofluorescent staining. And the accumulation of sulfated glycosaminoglycans was detected by Alcian blue staining. Meanwhile, the expressions of collagen I, X and cell adhesion molecule N-cadherin were assayed.RESULTS:The hUC-MSCs isolated from human umbilical cord stromas exhibited fibroblastic morphology and they were positive for CD29 (95.9%), CD44 (96.5%), CD90 (98.9%), CD105 (94.3%) and negative for hematopoietic stem cells surface markers CD34 (3.0%) and CD45 (2.6%). At Day 21, hUC-MSCs differentiated toward adiposity and osteogenesis. Both oil red O and alkaline phosphatase stains were intensely positive and it confirmed the multilineage potential of hUC-MSCs. An intense expression of GFP was observed under flourescence microscope and the transfection efficiency of cells with Lenti-GFP-SOX9 or Lenti-GFP was more than 90% respectively. SOX9 gene was over-expressed in hUC-MSCs at 48 h post-transduction. The proliferation of hUC-MSCs had no significant effect after the transfection of lentivirus vectors (P > 0.05). In vitro high-density monolayer culture of these SOX9-transfected hUC-MSCs demonstrated that spontaneous cell aggregation appeared at Day 14 of culturing and subsequently generated large cartilage nodules. However there was no phenomenon of cell aggregation occurring in the cells transducted by Lenti-GFP or untransduced vectors. The expressions of collagen II and Aggrecan were higher in SOX9 transducted cells than those in the controls. Alcian blue staining also showed abundant accumulation of sulfated glycosaminoglycans in the SOX9-induced cartilage nodules. The expression of collagen I had no difference in all groups and collagen X was inhibited in SOX9 transduced cells. N-cadherin was strongly up-regulated by SOX9 and might result in cellular aggregation and formation of large cartilage nodules.CONCLUSION:SOX9 may enhance the chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation.

Activating UCHL1 through the CRISPR activation system promotes cartilage differentiation mediated by HIF‐1α/SOX9

Molecular and Cellular Characterization During Chondrogenic Differentiation of Adipose Tissue-Derived Stromal Cells in Vitro and Cartilage Formation in Vivo

Cartilage Repair Using Hyaluronan Hydrogel-Encapsulated Human Embryonic Stem Cell-Derived Chondrogenic Cells

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Characterization of Sox9-overexpressing Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Based Engineered Cartilage Both in Vitro and in Vivo.

Lentivirus-mediated knockdown of aggrecanase-1 and -2 promotes chondrocyte-engineered cartilage formation in vitro.

HIF-1α as a Regulator of BMP2-Induced Chondrogenic Differentiation, Osteogenic Differentiation, and Endochondral Ossification in Stem Cells.

CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis

Delivery of the Sox9 Gene Promotes Chondrogenic Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in an in Vitro Model.

Construction of tissue engineered cartilage with Sox9 gene transfection human umbilical cord blood-derived mes-enchymal stem cells and BMG/fibrin

Direct Reprogramming of Mouse Subchondral Bone Osteoblasts into Chondrocyte-like Cells

Long noncoding RNA UCA1 promotes the chondrogenic differentiation of human bone marrow mesenchymal stem cells via regulating PARP1 ubiquitination

[SOX9 Enhanced Chondrogenic Differentiation Potential of Human Umbilical Cord Mesenchymal Stem Cells Through Cellular Aggregation].

Long non-coding RNA MIR22HG suppresses the chondrogenic differentiation of human adipose-derived stem cells by interacting with CTCF to upregulate CRLF1

Long noncoding RNA UCA1 promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells via miRNA-145-5p/SMAD5 and miRNA-124-3p/SMAD4 axis.

Promotion of osteochondral repair through immune microenvironment regulation and activation of endogenous chondrogenesis via the release of apoptotic vesicles from donor MSCs

SIRT1 activity orchestrates ECM expression during hESC-chondrogenic differentiation

Temporal Activation of Β-Catenin Signaling in the Chondrogenic Process of Mesenchymal Stem Cells Affects the Phenotype of the Cartilage Generated

Mir-194 Regulates Chondrogenic Differentiation Of Human Adipose-Derived Stem Cells By Targeting Sox5

Time- and cell-specific activation of BMP signaling restrains chondrocyte hypertrophy

Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Induced by Acellular Cartilage Sheets.